Daeryun Law Firm successfully completed seminar on ‘Compliance issues and practices in the pharmaceutical field’
Focus on pharmaceutical law revision, CSOIntroduction of reporting system, disclosure of expenditure reports, etc. 7Day ‘Compliance issues and practices in the pharmaceutical sector’A seminar on the theme was held at Daeryun Law Firm's headquarters in Yeouido, Seoul..This seminar was held last year in accordance with the revision of the Pharmaceutical Affairs Act. 10Monthly drug promotion salesperson(CSO) As regulations on illegal rebates in the pharmaceutical industry are being strengthened, including the implementation of a reporting system,, It was designed to explore response strategies for related companies..Seminars held online and offline included top domestic pharmaceutical companies., Bio/healthcare company affiliated with a large corporation, Legal affairs for global pharmaceutical companies, etc., compliance, Executives and staff in charge of the audit department 80More than 20 people attended, reflecting the industry's keen interest..gun 4This seminar, which was held in 2 sessions, included Choi Yun-jeong, attorney at Daeryun Medical Pharmaceutical Group,, Gyejun Son, Attorney at Corporate Legal Group, Advisor Choi Myeong-soon, Tax accountant Lim Jeong-oh participated.. In the first session, Attorney Yoonjeong Choi CSO We introduced the reporting system and the system for disclosing expenditure reports on details of economic benefits, which has been in full effect since this month..Attorney Choi “CSOWith the implementation of the reporting system, drug and medical device promotion salesmen are required to report., Pharmaceutical companies, etc. did not report CSOSales promotion work could no longer be entrusted to”said. also, About expenditure reports “CSO Since it is also included in the writing entity, it is a provider of economic benefits that is permitted., Scope and Content, There is a need to check and respond to regulations regarding storage of related data, etc.”as “Please note that if you violate the above reporting and expense report regulations, you may be subject to criminal punishment as well as administrative measures.”advised.In the second session, Attorney Kyejun Son, head of the Corporate Legal Group, discussed pharmaceutical industry rebate regulations and fair trade compliance programs.(CP)conducted an in-depth analysis of. Attorney Son analyzed cases of sanctions by the Fair Trade Commission and identified pharmaceutical companies as CP Presented a construction strategy.he is “CP Grading follows the evaluation criteria specified in the regulations on operation and evaluation.. It is a system where grades are given based on the calculated scores., Excellent grade companies will be fined, You can receive benefits such as reduction in corrective action.”as “Many pharmaceutical companies are already responding by forming dedicated departments.. Set a target grade CP It is necessary to establish an operation plan and inspect it through a checklist.”advised.In particular, Attorney Son said, is the efforts of the working staff also important? CEOHe said that it was necessary to strengthen the capabilities of the dedicated department as the will to implement and support also accounted for a large portion of the evaluation items.. As a solution to this △Best practice analysis △We proposed the discovery of improvements through inspection by external experts..The third presentation was by the Health Insurance Review and Assessment Service.(HIRA) Advisor Choi Myeong-soon, who served as the head of the Gwangju branch, took charge.. When Advisor Choi served as the director of the Pharmaceutical Management Information Center, he was the first in the country to ‘Pharmaceutical Distribution Management Team’By establishing a new system, it has contributed to the management of the pharmaceutical distribution system and the establishment of a foundation for the rebate investigation system..From a practical perspective, he discusses the characteristics and current status of the domestic and international pharmaceutical markets., Analyzed administrative dispositions for drugs that disrupted distribution order.. Advisor Choi “The domestic pharmaceutical industry is(generic drug) As a result of excessive sales competition centered on the domestic market,, Rebates that provide unfair profits to medical institutions have become prevalent.”While analyzing, Pharmaceutical industry rebate investigation and investigation cooperation system, HIRA's pharmaceutical supply history follow-up management and expenditure report investigation, Introduced rebate pharmaceutical administrative disposition practices, etc..At the end of his presentation, he “pharmaceutical, For the development of the wholesale and distribution industry, an environment for new drug development and quality improvement must be created.”suggested.In the last session, hospitals and clinics, Lim Jeong-oh, a tax accountant who has provided tax adjustment and advice for manufacturing companies, appeared as a presenter.. Tax accountant Lim explained tax issues that may arise when rebates are discovered and corporate response measures..Lim Tax Accountant “Past tax investigations were a structural constraint on the pharmaceutical market., Due to limitations in rebate tracking manpower and time, only corporate tax was imposed on providers.”as “However, the recent trend of tax investigations is to focus on revealing the attribution of income.. Therefore, if you are under investigation, you must respond by checking every detail.”He emphasized.Here, tax accountant Lim is subject to imprisonment and fines in the case of rebate providers.(It is possible to impose a necessary combination of punishment by subjecting more than one punishment at the same time.)He explained that this is possible, so caution is required..CEO Kook-il Kim “In the pharmaceutical industry, compliance is becoming increasingly important in operating a company stably.”as “We plan to hold regular seminars in the future to provide time to think together about difficulties within the industry, so please give us your interest.”He said.one side, Daeryun Medical & Pharmaceutical Group has pharmaceutical, bio, and healthcare centers under its umbrella., We provide services such as advisory, litigation, and legal consulting to help companies minimize legal risks..In addition, the group is led by group leader Song Jin-seong, a former doctor, and center director Lee Seo-hyung, who advises organizations such as the Ministry of Health and Welfare and the Korea Disease Control and Prevention Agency., Attorney Lee Il-hyung with experience at Celltrion and patent law firm, Soyoung Yoon, a lawyer with experience at the Ministry of Health and Welfare and HIRA, Attorney Choi Yoon-jeong, who advises companies such as pharmaceutical companies., Advisor Choi Myeong-soon, who served as the head of the HIRA Gwangju Branch, is active.. Reporter Park Jun-sik(parkjs@wowtv.co.kr) [View full article]
Korea Economic Daily TV - Daeryun Law Firm successfully concludes seminar on ‘Compliance issues and practices in the pharmaceutical sector’ (Go here)
Law News - Daeryun successfully concludes seminar on ‘Compliance issues and practices in the pharmaceutical sector’ (Go here)